proof of principle to progress treatments
Published 5 years ago • 20 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
3:38
insights into epim-001 for the treatment of hematological malignancies
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
5:30
changing perceptions of mgus progression: explaining the data
-
21:38
drawing the line: the rationale behind blood tube collection order
-
2:59
what is mgus?
-
2:01
the evolution of bcl2 inhibition in cll
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
0:52
a real-world study of the optimal duration of cpx-351 treatment in patients with aml
-
1:53
the future of multiple myeloma treatment
-
0:58
current research and next steps to improve the understanding and management of icaht
-
2:09
heart transplantation in attr amyloidosis
-
1:27
current diagnostic modalities for the identification of ptld
-
0:54
a research update in richter's transformation from ash 2023
-
9:25
mgus diagnosis: a step-by-step approach
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing